My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Karur Vysya Bank turns volatile after huge bulk deal
Feb 17,2017

Meanwhile, the S&P BSE Sensex was up 167.37 points, or 0.59%, to 28,468.64

On BSE, so far 2.42 crore shares were traded in the counter, compared with average daily volume of 67,396 shares in the past one quarter. The stock saw high intraday volatility. The stock hit a high of Rs 94.80 and a low of Rs 91 so far during the day. The stock hit a 52-week high of Rs 108.28 on 11 July 2016. The stock hit a 52-week low of Rs 78.78 on 29 February 2016.

The mid-cap private sector bank has equity capital of Rs 121.86 crore. Face value per share is Rs 2.

Karur Vysya Banks net profit dropped 24.26% to Rs 115.76 crore on 3.68% rise in total income to Rs 1581.26 crore in Q3 December 2016 over Q3 December 2015.

Karur Vysya Bank has 667 branches and 1655 ATMs as on 31 March 2016.

Powered by Capital Market - Live News

Venus Remedies spurts on QIP plan
Feb 17,2017

The announcement was made during trading hours today, 17 February 2017.

Meanwhile, the BSE Sensex was up 166.87 points, or 0.59%, to 28,468.14.

On the BSE, so far 1.67 lakh shares were traded in the counter, compared with average daily volumes of 31,821 shares in the past one quarter. The stock had hit a high of Rs 106.40 and a low of Rs 95 so far during the day.

The stock hit a 52-week high of Rs 142.80 on 5 October 2016. The stock hit a 52-week low of Rs 65 on 1 June 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, falling 9.07% compared with the 3.83% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 11.54% as against Sensexs 8.23% rise.

The small-cap company has equity capital of Rs 11.44 crore. Face value per share is Rs 10.

Venus Remedies reported net loss of Rs 2.10 crore in Q3 December 2016 as against net loss of Rs 0.25 crore in Q3 December 2015. Net sales declined 12.61% to Rs 84.49 crore in Q3 December 2016 over Q3 December 2015.

Venus Remedies is a pharmaceutical company.

Powered by Capital Market - Live News

HDFC Bank leads gainers on BSEs A group
Feb 17,2017

HDFC Bank rose 7.05% at Rs 1,420.90. The stock topped the gainers in A group. On the BSE, 42.98 lakh shares were traded on the counter so far as against the average daily volumes of 65,000 shares in the past two weeks.

VA Tech Wabag rose 5.24% at Rs 520.50. The stock was the second biggest gainer in A group. On the BSE, 38,000 shares were traded on the counter so far as against the average daily volumes of 6,277 shares in the past two weeks.

Dewan Housing Finance Corporation rose 4.65% at Rs 318.75. The stock was the third biggest gainer in A group. On the BSE, 4.49 lakh shares were traded on the counter so far as against the average daily volumes of 2.50 lakh shares in the past two weeks.

Repco Home Finance rose 4.69% at Rs 662.45. The stock was the fourth biggest gainer in A group. On the BSE, 14,000 shares were traded on the counter so far as against the average daily volumes of 21,000 shares in the past two weeks.

Cadila Healthcare rose 4.32% at Rs 448. The stock was the fifth biggest gainer in A group. On the BSE, 9.67 lakh shares were traded on the counter so far as against the average daily volumes of 1.51 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Virinchi jumps after multi-year contract
Feb 17,2017

The announcement was made during trading hours today, 17 February 2017.

Meanwhile, the BSE Sensex was up 259.76 points, or 0.92%, to 28,561.03.

On the BSE, so far 1.56 lakh shares were traded in the counter, compared with average daily volumes of 78,582 shares in the past one quarter. The stock had hit a high of Rs 89.90 and a low of Rs 85 so far during the day.

The stock hit a 52-week high of Rs 94.80 on 16 January 2017. The stock hit a 52-week low of Rs 29.45 on 26 February 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, falling 1.55% compared with the 3.83% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 43.71% as against Sensexs 8.23% rise.

The small-cap company has equity capital of Rs 17.99 crore. Face value per share is Rs 10.

Virinchi said it has signed up a multi-year contract for its flagship product QFundTM with one of the leading lenders of alternative financing industry in USA based out of Midwestern region of USA, operating through their 300 branches spread across 14 states of USA apart from lending through their online channels. Virinchis Cloud solution will replace the entire present IT infrastructure of the lender.

Over the first three years of the contract starting January 2017, Virinchi is expected to generate an annuity revenue of $3.5 million and services revenue of another $2.5 million, totaling a $6 million revenue addition over the same period.

On a consolidated basis, Virinchis net profit surged 100% to Rs 4.86 crore on 39.61% increase in net sales to Rs 77.75 crore in Q3 December 2016 over Q3 December 2015.

Virinchi is an IT products & services company focusing on customers in North America, Europe, & Middle East. Virinchi is currently a software service provider to retail micro lending industry in North America, the company operates through its subsidiary QFund Technologies, Inc a 100% subsidiary of Virinchi in USA.

Powered by Capital Market - Live News

Volumes jump at Karur Vysya Bank counter
Feb 17,2017

Karur Vysya Bank clocked volume of 237.11 shares by 12:21 IST on BSE, a 292.80-times surge over two-week average daily volume of 81,000 shares. The stock rose 2.18% to Rs 93.60.

Sobha notched up volume of 3.82 lakh shares, a 96.93-fold surge over two-week average daily volume of 4,000 shares. The stock shed 0.44% to Rs 285.

FDC saw volume of 7.04 lakh shares, a 62.5-fold surge over two-week average daily volume of 11,000 shares. The stock rose 2.1% to Rs 214.

HDFC Bank clocked volume of 35.78 lakh shares, a 55.24-fold surge over two-week average daily volume of 65,000 shares. The stock jumped 7.17% to Rs 1,422.55.

Grindwell Norton saw volume of 2.04 lakh shares, a 31.86-fold rise over two-week average daily volume of 6,000 shares. The stock rose 3.05% to Rs 330.75.

Powered by Capital Market - Live News

HDFC Bank leads gainers in A group
Feb 17,2017

HDFC Bank jumped 7.22% to Rs 1,423.25 at 12:13 IST. The stock topped the gainers in the BSEs A group. On the BSE, 35.75 lakh shares were traded on the counter so far as against the average daily volumes of 65,000 shares in the past two weeks.

VA Tech Wabag surged 5.14% to Rs 520. The stock was the second biggest gainer in A group. On the BSE, 33,000 shares were traded on the counter so far as against the average daily volumes of 6,277 shares in the past two weeks.

Repco Home Finance gained 4.41% at Rs 660.70. The stock was the third biggest gainer in A group. On the BSE, 10,000 shares were traded on the counter so far as against the average daily volumes of 21,000 shares in the past two weeks.

Cadila Healthcare advanced 4.24% at Rs 447.65. The stock was the fourth biggest gainer in A group. On the BSE, 9.08 lakh shares were traded on the counter so far as against the average daily volumes of 1.51 lakh shares in the past two weeks.

Castrol India rose 3.88% to Rs 432.05. The stock was the fifth biggest gainer in A group. On the BSE, 1.08 lakh shares were traded on the counter so far as against the average daily volumes of 61,000 shares in the past two weeks.

Powered by Capital Market - Live News

NTPC gains after Jharkhand coal mine kicks off operation
Feb 17,2017

Meanwhile, the BSE Sensex was up 204.12 points, or 0.72%, to 28,505.39.

On the BSE, so far 75,000 shares were traded in the counter, compared with average daily volumes of 3.82 lakh shares in the past one quarter. The stock had hit a high of Rs 170.90 and a low of Rs 169.35 so far during the day.

The stock hit a 52-week high of Rs 177.80 on 27 January 2017. The stock hit a 52-week low of Rs 116.80 on 25 February 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, falling 1.53% compared with the 3.83% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 7.25% as against Sensexs 8.23% rise.

The large-cap company has equity capital of Rs 8245.46 crore. Face value per share is Rs 10.

NTPC announced after market hours yesterday, 16 February 2017, that the first rake of coal was flagged off on 16 February 2017 from the companys first coal mine, Pakri Barwadih in Jharkhand. This coal mine will have ultimate capacity of 18 million metric tonne per annum. In the next year, around 2-3 million metric tonne of coal is likely to be produced. As a basket source, coal will be supplied to different power stations of NTPC from this mine.

NTPCs net profit fell 7.5% to Rs 2468.72 crore on 11.1% rise in net sales to Rs 19287.47 crore in Q3 December 2016 over Q3 December 2015.

NTPC, Indias largest power company, has presence in the entire value chain of power generation business.

Powered by Capital Market - Live News

IDBI Bank trims intraday gains after announcing fund raising plan
Feb 17,2017

The announcement was made after market hours yesterday, 16 February 2017.

Meanwhile, the S&P BSE Sensex was up 217.67 points or 0.77% at 28,518.94

On BSE, so far 3.95 lakh shares were traded in the counter as against average daily volume of 4.39 lakh shares in the past one quarter. The stock trimmed intraday gains. The stock hit a high of Rs 82.10 and a low of Rs 80.85 so far during the day. The stock had hit a 52-week high of Rs 86.50 on 6 February 2017. The stock had hit a 52-week low of Rs 50.35 on 17 February 2016.

The large-cap bank has equity capital of Rs 2058.82 crore. Face value per share is Rs 10.

IDBI Bank reported net loss of Rs 2254.96 crore in Q3 December 2017, higher than net loss of Rs 2183.68 crore in Q3 December 2016. Total income fell 3.5% to Rs 7104.21 crore in Q3 December 2016 over Q3 December 2015.

Powered by Capital Market - Live News

Cadila Healthcare hits record high
Feb 17,2017

Meanwhile, the S&P BSE Sensex was up 200.33 points or 0.71% at 28,501.60.

On the BSE, 8.28 lakh shares were traded on the counter so far as against the average daily volumes of 1.51 lakh shares in the past two weeks. The stock had hit a high of Rs 460 so far during the day, which is also its record high. The stock hit a low of Rs 438.10 so far during the day. The stock had hit a 52-week low of Rs 305 on 12 April 2016.

Shares of Cadila Healthcare have rallied 25.4% in two trading sessions from its close of Rs 358.05 on 15 February 2017 after the company during market hours yesterday, 16 February 2017 said that the United States Food and Drug Administration (USFDA) issued no observation (483) after concluding the inspection of the companys Moraiya facility from 6 February 2017 to 15 February 2017. The stock had rallied 19.94% to settle at Rs 429.45 yesterday, 16 February 2017.

Cadila Healthcares consolidated net profit fell 34.6% to Rs 281.60 crore on 0.8% decrease in net sales to Rs 2249.60 in Q3 December 2016 over Q3 December 2015.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Biocon gains after USFDA accepts biosimilar pegfilgrastim for review
Feb 17,2017

The announcement was made after market hours yesterday, 16 February 2017.

Meanwhile, the BSE Sensex was up 156.94 points, or 0.55%, to 28,458.21.

On the BSE, so far 33,000 shares were traded in the counter, compared with average daily volumes of 71,907 shares in the past one quarter. The stock had hit a high of Rs 1,123 and a low of Rs 1,105 so far during the day. The stock hit a 52-week low of Rs 454.30 on 26 February 2016.

The stock had outperformed the market over the past 30 days till 16 February 2017, rising 10.40% compared with the 3.83% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 25.60% as against Sensexs 8.23% rise.

The large-cap company has equity capital of Rs 100 crore. Face value per share is Rs 5.

The US Food and Drug Administration (US FDA) has accepted Mylans Biologics License Application (BLA) for MYL44O1H, a proposed biosimilar to Neulasta (pegfilgrastim), for filingthrough the 351(k) pathway. The proposed biosimilar to Neulasta is used to reduce the duration of neutropenia (low count of neutrophils, a type of white blood cells) and the incidence of fever associated with neutropenia in adult patients treated with chemotherapy n++n certain types of cancer. The FDA goal date set under the Biosimilar User Fee Act (BsUFA) is 9 October 2017, the company said.

Biocon and Mylan are exclusive partners on a broad portfolio of biosimilars and generic insulin analogs. The proposed biosimilar pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace. Mylan has exclusive commercialization rights for the proposed biosimilar pegfilgrastim in the U.S., Canada, Japan, Australia, New Zealand and in the European Union and European Free Trade Association countries. Biocon has co-exclusive commercialization rights with Mylan for the product in the rest of the world.

On a consolidated basis, net profit of Biocon rose 64.55% to Rs 171.30 crore on 29.59% rise in net sales to Rs 1022.50 crore in Q3 December 2016 over Q3 December 2015.

Biocon is Indias largest and fully-integrated, innovation-led biopharmaceutical company.

Powered by Capital Market - Live News

Indiabulls Housing Finance and IOC gain on inclusion in Nifty 50 index
Feb 17,2017

Indiabulls Housing Finance (up 1.92%) and Indian Oil Corporation (up 1.65%), edged higher. Bharat Heavy Electricals (Bhel) (down 1.17%) and Idea Cellular (down 2.97%), edged lower.

Meanwhile, the S&P BSE Sensex was up 186.80 points or 0.66% at 28,488.07.

Bharat Heavy Electricals (Bhel) and Idea Cellular have been removed from the benchmark Nifty 50 index, NSEs index provider IISL said in a statement on Thursday, 16 February 2017. The two stocks will be replaced by Indiabulls Housing Finance and Indian Oil Corporation (IOC) instead, as part of the periodic review process. The changes will take effect from 31 March 2017, the statement added.

Powered by Capital Market - Live News

Siemens inches up after securing order
Feb 17,2017

The announcement was made after market hours yesterday, 16 February 2017.

Meanwhile, the S&P BSE Sensex was up 160.65 points or 0.57% at 28,461.92.

On the BSE, 3,057 shares were traded on the counter so far as against the average daily volumes of 23,278 shares in the past one quarter. The stock had hit a high of Rs 1,221 and a low of Rs 1,205 so far during the day.

The stock had hit a 52-week high of Rs 1,355.40 on 25 July 2016 and a 52-week low of Rs 973.20 on 29 February 2016. The stock had underperformed the market over the past one month till 16 February 2017, advancing 2.58% compared with the Sensexs 3.71% rise. The scrip had, however, outperformed the market over the past one quarter advancing 8.08% as against the Sensexs 7.61% rise.

The large-cap company has equity capital of Rs 71.22 crore. Face value per share is Rs 2.

The latest order secured by Siemens is for design, engineering, procurement, manufacture, supply and commissioning of equipment for a substation at Khandwa in Madhya Pradesh and for bay extension equipment at Dhule in Maharashtra for Khargone Transmission.

Siemens net profit rose 43.8% to Rs 160.01 crore on 1.4% decline in net sales to Rs 2234.38 crore in Q1 December 2016 over Q1 December 2015.

Siemens focuses on the areas of electrification, automation and digitalization. As on 31 December 2016, Siemens AG held 75% stake in Siemens.

Powered by Capital Market - Live News

Eveready Industries gains as board to consider business re-organisation
Feb 17,2017

The announcement was made after market hours yesterday, 16 February 2017.

Meanwhile, the S&P BSE Sensex was up 142.79 points, or 0.5%, to 28,444.06

On BSE, so far 321 shares were traded in the counter, compared with an average volume of 9,720 shares in the past one quarter. The stock hit a high of Rs 255 and a low of Rs 249.50 so far during the day. The stock hit a 52-week high of Rs 291 on 30 August 2016. The stock hit a 52-week low of Rs 190 on 29 December 2016.

The small-cap company has an equity capital of Rs 36.34 crore. Face value per share is Rs 5.

Net profit of Eveready Industries India rose 65.37% to Rs 35.19 crore on 1.7% rise in net sales to Rs 329.31 crore in Q3 December 2016 over Q3 December 2015.

Eveready Industries India is the market leader of dry cell batteries. Apart from dry cell batteries, the company is also the market leader in flashlights. Eveready also markets LED, CFL, GLS lamps & other lighting products and rechargeable lanterns & devices, and packet tea.

Powered by Capital Market - Live News

HDFC Bank spurts as RBI withdraws foreign investment curbs
Feb 17,2017

The announcement was made after market hours yesterday, 16 February 2017.

Meanwhile, the BSE Sensex was up 227.46 points, or 0.80%, to 28,528.73.

On the BSE, so far 12.21 lakh shares were traded in the counter, compared with average daily volumes of 1.81 lakh shares in the past one quarter. The stock hit a high of Rs 1,450 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 1,414 so far during the day. The stock hit a 52-week low of Rs 928.80 on 29 February 2016.

The large-cap private sector bank has equity capital of Rs 511.66 crore. Face value per share is Rs 2.

The Reserve Bank of India (RBI) notified that the aggregate foreign shareholding through American Depository Receipts (ADR)/Global Depository Receipts (GDR)/ Foreign institutional Investors (FIIs)/Foreign Portfolio Investors (FPIs)/ Foreign Direct Investment (FDI)/Non-Resident Indians (NRIs)/ Persons of Indian Origin (PIOs) in HDFC Bank have gone below the prescribed limit stipulated under the extant FDI Policy. Hence the restrictions placed on the purchase of shares of the above company are withdrawn with immediate effect.

HDFC Banks net profit rose 15.15% to Rs 3865.33 crore on 13.5% increase in operating income to Rs 20748.27 crore in Q3 December 2016 over Q3 December 2015.

Powered by Capital Market - Live News

MCX gains after signing MoU with Singapore Diamond Investment Exchange
Feb 16,2017

The announcement was made during market hours today, 16 February 2017.

Meanwhile, the BSE Sensex was up 132.85 points, or 0.47%, to 28,288.41

On BSE, so far 56,000 shares were traded in the counter, compared with average daily volume of 84,533 shares in the past one quarter. The stock hit a high of Rs 1,126.95 and low of Rs 1,101 so far during the day. The stock hit a 52-week high of Rs 1,420 on 3 October 2016. The stock hit a 52-week low of Rs 732 on 17 February 2016.

The mid-cap company has equity capital of Rs 51 crore. Face value per share is Rs 10.

Multi Commodity Exchange of India (MCX) and Singapore Diamond Investment Exchange (SDiX), the worlds first and only commodity exchange trading in physically settled diamonds, announced signing of a Memorandum of Understanding (MoU) for establishing areas of cooperation between the two exchanges. The MoU is intended to facilitate cooperation between the two exchanges in areas such as knowledge sharing and research, standardization of the product for Indian markets and enhancing transparency in pricing, as well as to explore areas for further collaboration between the exchanges.

India is the largest global hub for the cutting and polishing of diamonds, and has several thousand small medium and large enterprises which are involved in the diamond business. Moreover, through this partnership, the exchanges have agreed to work towards the goal of assisting the stakeholders in Indias diamond industry by bringing international best practices in price risk management and price discovery through innovative spot and derivative market operations. The move will also foster the development of communication channels for the sharing of information between the exchanges.

Mrugank Paranjape, MD & CEO, MCX said that the MoU will support the mutual interests of MCX and SDiX towards establishing price discovery, enhancing transparency in prices and help the value-chain with a risk management platform, in a commodity like diamond in which India has a significant global presence.

MCXs net profit rose 93.83% to Rs 33.94 crore on 29.07% rise in total income to Rs 99.77 crore in Q3 December 2016 over Q3 December 2015.

MCX is Indias first listed, national-level, electronic, commodity futures exchange with permanent recognition from the Government of India. Various commodities across segments are traded on MCX. These include bullion, energy, metals and agri commodities.

Powered by Capital Market - Live News